Transforming Autoimmune Clinical Trial Recruitment
At Trialbee, we connect people living with autoimmune conditions to innovative clinical trials designed to restore health, balance, and quality of life. Through patient-centric strategies and data-driven insights, we help sponsors accelerate recruitment, enhance diversity, and bring new autoimmune therapies to patients faster.
Key Challenges in Autoimmune Trials
Autoimmune studies face complex recruitment barriers stemming from diagnostic uncertainty, overlapping symptoms, and patient burden. These challenges can slow timelines, limit diversity, and increase study costs.
-
Heterogeneous Disease Profiles
Autoimmune conditions present with diverse symptoms, progression rates, and treatment histories, making precise eligibility determination difficult.
-
Limited Awareness & Underdiagnosis
Many patients experience years-long diagnostic journeys and lack awareness of clinical research as a care option.
-
Comorbidity Complexity
High rates of overlapping autoimmune conditions and coexisting chronic illnesses complicate trial design and screening.
The result: delayed site activation, low referral-to-randomization rates, and missed opportunities to engage qualified, motivated participants.
Trialbee’s Solution
At Trialbee, we deliver patient-focused, technology-driven recruitment strategies tailored for autoimmune clinical trials. Our digital ecosystem combines omnichannel outreach, medical pre-qualification, and transparent analytics — all designed to accelerate enrollment while maintaining quality.
Precision Recruitment & Omnichannel Reach
We connect with patients where they already seek information and support — online, within advocacy groups, and across social and healthcare networks. Trialbee leverages behavioral insights, real-world data, and targeted digital engagement to reach verified, interested participants.
Two-Stage Medical Pre-Qualification
Each referred patient completes digital pre-screening and eligibility verification based on medical history, symptoms, and diagnosis data. This ensures that sites receive pre-qualified, motivated participants who are ready to take part.
Real-Time Visibility & Analytics with Honey™ Platform
Our Honey™ platform provides transparent, real-time insights into recruitment performance, referral status, and site-level progress. Sponsors and CROs can monitor every step of the patient journey — enabling proactive, data-driven decision-making.
Proven Experience Across Key Indications
- Celiac Disease
- Crohn's Disease
- Immune Thrombocytopenic Purpura (ITP)
- Lupus
- Multiple Sclerosis
- Myasthenia Gravis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Type 1 Diabetes
- Ulcerative Colitis
Purpose-Built Creative for Autoimmune Trials
Autoimmune conditions often affect every part of a patient’s daily life — from energy to mobility to emotional well-being. Trialbee develops empathetic, inclusive campaigns that honor these lived experiences. Our creative approach reflects the resilience and diversity of the autoimmune community, ensuring every message connects authentically and inspires participation.
Autoimmune Resources
From Volume to Precision: Recruitment Strategies for Trial-Ready Rheumatoid Arthritis Patients
Case Study | Contributed 30% of Consents in Celiac Trial
Let’s Partner for Better, Faster Recruitment
Whether you’re conducting a study in inflammatory bowel disease, liver conditions, or rare gastrointestinal disorders, Trialbee helps you connect with qualified patients — faster. Learn how our technology, data, and human-centered approach deliver measurable recruitment success.
